Neoplasm, Liver Clinical Trial
Official title:
A Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Left-sided Hepatectomy
Open versus Laparoscopic Left-sided Hepatectomy (OLLEH) trial Multi-institutional,
prospective and randomized trial in patients undergoing left sided hepatectomy through
laparoscopic versus open procedure.
Primary endpoint: Functional recovery Secondary endpoint: Hospital duration, estimated blood
loss, operation time, resection margin status, postoperative complication, mortality, liver
function laboratory test, re-admission, quality of life, cosmesis, cost effectiveness
Laparoscopic left-sided hepatectomy is widely performed for the treatment of various hepatic
neoplasms. Many studies have reported that laparoscopic left-sided hepatectomy is safe and
effective compared with open conventional left-sided hemihepatectomy. However, prospective
study is rare and there is no randomized controlled trial.
The surgeons who are affiliated at a medical center in capital area of Korea launched the
Open versus Laparoscopic Left-sided Hepatectomy (OLLEH) trial to verify the surgical outcome
of laparoscopic left-sided hepatectomy.
Laparoscopic surgery has benefits that less wound and less pain. The hypothesis of the study
is 'The laparoscopic left-sided hemihepatectomy is better than open surgery from functional
recovery.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06118125 -
Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement
|